TNF and metabolic dysfunction-associated steatohepatitis: Reduced levels of the inflammation factors TNFα and IL-6 in plasma and of TGF-ß, monocyte chemoattractant protein-1, matrix metalloproteinase-9 and TNFα in the liver inhibited the development of NASH and NAFLD (159).